Kristin Labate

Kristin Labate has a strong background in the pharmaceutical industry, with their most recent role as Associate Director, Hematology Strategic Accounts at ADC Therapeutics. In this position, they lead a local team and is responsible for developing and executing business plans for top customer accounts, while also educating key stakeholders on the clinical profile and value proposition of the company's product, Zynlonta. Prior to this, they worked as a Hematology Therapeutic Specialist at ADC Therapeutics.

Before joining ADC Therapeutics, Kristin served as a Territory Manager at Stemline Therapeutics, Inc. from 2018 to 2021. Kristin also has experience at Takeda Oncology, where they held the position of Regional Account Manager from 2017 to 2018.

Earlier in their career, Kristin worked at ARIAD Pharmaceuticals, Inc. as a Regional Account Manager from 2012 to 2017. Kristin also held roles as an Oncology Sales Specialist at both Eisai and MGI Pharma, from 2008 to 2012 and 2007 to 2008, respectively. Prior to that, they worked as an Oncology Product Specialist at Ortho Biotech from 2002 to 2007. Overall, Kristin has a wealth of experience in pharmaceutical sales and account management within the oncology field.

Kristin Labate attended Saint Joseph's University from 1996 to 2000, where they obtained a Bachelor of Applied Science (B.A.Sc.) degree in Pharmaceutical Marketing and Management.